Richard Leconey
Public Health & General Preventive Medicine · Alvin, TXNPI 1104802461
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,788 of the $24,145 with a category attached, or 73.7%. AbbVie accounts for 97.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $7,098 and has fallen 73.0% since, to $1,917 in 2025. Among public health & general preventive medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $78.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Galderma Laboratories, L.p.$614
- Revance Therapeutics, Inc.$26
What the payments were for
- Speaking & faculty fees$17,78874%
- Food & beverage$6,35826%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 286 | $23,505 |
| Galderma Laboratories, L.p. | 20 | $614 |
| Revance Therapeutics, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$742
- BOTOX COSMETIC$617
How this compares
$24,145 in reported general payments places this provider in the 90th percentile of 41 public health & general preventive medicine providers in Texas.
See all public health & general preventive medicine providers in Texas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armour ThyroidThyroid,pork | 22 | $1,701 |
| Gabapentin | 16 | $121 |
| Levothyroxine Sodium | 11 | $89 |
| Spironolactone | 12 | $34 |
| Trazodone Hcl | 12 | $0 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieArmour Thyroid | $23,505 | $1,70122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 41 public health & general preventive medicine providers in Texas.
Other public health & general preventive medicine in Alvin
- Christopher LucciRockport$901K
- James SheehanFort Sam Houston$287K
- Barry DavisHouston$57K
- Tyler CooperDallas$2K
- Prathima NagireddyFort Worth$2K
- John CarloDallas$1K
- Olivia IvyAustin$685
- Ryan GottfredsonJbsa Lackland$490
- Steven ClarkDallas$476
- Joseph CleaverDallas$331
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.